684 related articles for article (PubMed ID: 31308194)
1. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid upregulates the expression of the p75NTR/sortilin receptor complex to induce neuronal apoptosis.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
Apoptosis; 2020 Oct; 25(9-10):697-714. PubMed ID: 32712736
[TBL] [Abstract][Full Text] [Related]
3. Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2.
Chandwani S; Keilani S; Ortiz-Virumbrales M; Morant A; Bezdecny S; Ehrlich ME
PLoS One; 2013; 8(10):e76842. PubMed ID: 24204683
[TBL] [Abstract][Full Text] [Related]
4. Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons.
Dedoni S; Olianas MC; Ingianni A; Onali P
J Neurochem; 2012 Jul; 122(1):58-71. PubMed ID: 22533963
[TBL] [Abstract][Full Text] [Related]
5. The Neurotrophin Receptor TrkC as a Novel Molecular Target of the Antineuroblastoma Action of Valproic Acid.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360553
[TBL] [Abstract][Full Text] [Related]
6. Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy.
Wu J; Dong L; Zhang M; Jia M; Zhang G; Qiu L; Ji M; Yang J
Neurochem Res; 2013 Nov; 38(11):2440-9. PubMed ID: 24072674
[TBL] [Abstract][Full Text] [Related]
7. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling.
Kimura A; Namekata K; Guo X; Noro T; Harada C; Harada T
Am J Pathol; 2015 Mar; 185(3):756-64. PubMed ID: 25542970
[TBL] [Abstract][Full Text] [Related]
9. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush.
Zhang ZZ; Gong YY; Shi YH; Zhang W; Qin XH; Wu XW
Neuroscience; 2012 Nov; 224():282-93. PubMed ID: 22867974
[TBL] [Abstract][Full Text] [Related]
10. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
[TBL] [Abstract][Full Text] [Related]
12. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
14. Brainstem brain-derived neurotrophic factor signaling is required for histone deacetylase inhibitor-induced pain relief.
Tao W; Chen Q; Wang L; Zhou W; Wang Y; Zhang Z
Mol Pharmacol; 2015 Jun; 87(6):1035-41. PubMed ID: 25852071
[TBL] [Abstract][Full Text] [Related]
15. Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons.
Osborne A; Wang AXZ; Tassoni A; Widdowson PS; Martin KR
Hum Gene Ther; 2018 Jul; 29(7):828-841. PubMed ID: 29466871
[TBL] [Abstract][Full Text] [Related]
16. Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway.
Choi J; Hwang J; Ramalingam M; Jeong HS; Jang S
BMC Neurosci; 2023 May; 24(1):28. PubMed ID: 37127577
[TBL] [Abstract][Full Text] [Related]
17. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
18. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
Foti SB; Chou A; Moll AD; Roskams AJ
Int J Dev Neurosci; 2013 Oct; 31(6):434-47. PubMed ID: 23542004
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
Fukuchi M; Nii T; Ishimaru N; Minamino A; Hara D; Takasaki I; Tabuchi A; Tsuda M
Neurosci Res; 2009 Sep; 65(1):35-43. PubMed ID: 19463867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]